|This Slide: #36 of 100|
Slide #36. Forest Laboratories, Inc. — Aptalis
Forest Laboratories, Inc. (FRX)
Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, today announced the completion of its acquisition of Aptalis, a privately held specialty pharmaceutical company focused on gastrointestinal disorders and cystic fibrosis. The companies will begin combined operations today, with Aptalis operating as a subsidiary of Forest Laboratories, Inc.
Forest Road is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Open the FRX Page at The Online Investor »
Free FRX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.47 out of 4)
(ranked higher than approx. 64% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite